Louise Frederika Kooij, Chief Accounting Officer at NewAmsterdam Pharma Co N.V. (NAMS), sold 72,572 shares at $33.44 ($2.4M) on 2026-01-23, disclosed to the SEC on 2026-01-27.
Open-market sale of $2.4M NAMS by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.44 | 25,405 | $850K | 35.2% |
| 2 | $34.37 | 12,767 | $439K | 18.2% |
| 3 | $32.77 | 34,091 | $1.1M | 46.2% |
| 4 | $33.45 | 309 | $10K | 0.4% |
| Total | $33.29 avg | 72,572 | $2.4M | 100% |
| Filing → |
| NAMS | SELL | 2026-05-27 | $2.3M | — | Filing → |
| NAMS | SELL | 2026-01-29 | $2.3M | — | Filing → |
| NAMS | SELL | 2026-01-07 | $88K | — | Filing → |